SvedbergOpen

Volume 3, Issue 1, March 2023

Review Article
OpenAccess

Tucaresol: A Unique Oral Candidate Drug Ideally Accessible for Treatment of Covid-19 Disease

Christopher L. Penney^1*, Boulos Zacharie² and Jean-Simon Duceppe³

Afr.J.Pharm.Sci. 3(1) (2023) 1-13, DOI: https://doi.org/10.51483/AFJPS.3.1.2023.1-13

Received: 24/11/2022|Accepted: 17/02/2023|Published: 05/03/2023

Abstract | Full Text Access | Download | XML

Review Article
OpenAccess

Maximizing Benefits of Traditional and Alternative Medicine in a Modern Era of Pharmacotherapy

Godfrey Mayoka^1* and Peter Mubanga Cheuka²

Afr.J.Pharm.Sci. 3(1) (2023) 14-30, DOI: https://doi.org/10.51483/AFJPS.3.1.2023.14-30

Received: 17/07/2022|Accepted: 22/01/2023|Published: 05/03/2023

Abstract | Full Text Access | Download | XML

Research Paper
OpenAccess

A Ceramide Isolated from Tinospora cordifolia (Menispermaceae) with Acetylcholinesterase Inhibitory Activity and Molecular Docking Study

O.J. Onoja^1,2*, T.O. Elufioye³, J.I. Olawuni⁴, Z.A. Sherwani⁵, and Z. Ul-Haq⁶

Afr.J.Pharm.Sci. 3(1) (2023) 31-41, DOI: https://doi.org/10.51483/AFJPS.3.1.2023.31-41

Received: 26/08/2022|Accepted: 11/02/2023|Published: 05/03/2023

Abstract | Full Text Access | Download | XML

Short Communication
OpenAccess

The Assessment of Anticoagulative System: Two Natural Anticoagulants Protein C and Antithrombin III

George Zhu^1*

Afr.J.Pharm.Sci. 3(1) (2023) 42-47, DOI: https://doi.org/10.51483/AFJPS.3.1.2023.42-47

Received: 06/09/2022|Accepted: 29/01/2023|Published: 05/03/2023

Abstract | Full Text Access | Download | XML

Research Paper
OpenAccess

Microsponges as a Novel and New Approach Delivery System

Manorama Ashok Sonavane¹ and Shweta, S. Saboo^2*

Afr.J.Pharm.Sci. 3(1) (2023) 48-60, DOI: https://doi.org/10.51483/AFJPS.3.1.2023.48-60

Received: 22/08/2022|Accepted: 14/02/2023|Published: 05/03/2023

Abstract | Full Text Access | Download | XML

Review Article
OpenAccess

Herbal Medicine Practice in Kenya: Challenges, Opportunities, and the Way Forward

Julia Kimondo^1*, Godfrey Mayoka¹, and Elizabeth Odongo²

Afr.J.Pharm.Sci. 3(1) (2023) 61-72, DOI: https://doi.org/10.51483/AFJPS.3.1.2023.61-72

Received: 23/12/2022|Accepted: 19/02/2023|Published: 05/03/2023

Abstract | Full Text Access | Download | XML

Research Paper
OpenAccess

Efficacy of Favipiravir and Remdesivir in the Treatment of Hospitalized Covid-19 Patients in Basrah, Iraq

Ahmed H Al-Darraji^1*

Afr.J.Pharm.Sci. 3(1) (2023) 73-80, DOI: https://doi.org/10.51483/AFJPS.3.1.2023.73-80

Received: 08/12/2022|Accepted: 21/02/2023|Published: 05/03/2023

Abstract | Full Text Access | Download | XML

African Journal of Pharmaceutical Sciences

All Issues

Tucaresol: A Unique Oral Candidate Drug Ideally Accessible for Treatment of Covid-19 Disease

Maximizing Benefits of Traditional and Alternative Medicine in a Modern Era of Pharmacotherapy

A Ceramide Isolated from Tinospora cordifolia (Menispermaceae) with Acetylcholinesterase Inhibitory Activity and Molecular Docking Study

The Assessment of Anticoagulative System: Two Natural Anticoagulants Protein C and Antithrombin III

Microsponges as a Novel and New Approach Delivery System

Herbal Medicine Practice in Kenya: Challenges, Opportunities, and the Way Forward

Efficacy of Favipiravir and Remdesivir in the Treatment of Hospitalized Covid-19 Patients in Basrah, Iraq